We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Danaher Corp (DHR) Common Stock USD0.01

Sell:$257.99 Buy:$258.00 Change: $4.53 (1.79%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Ex-dividend
Sell:$257.99
Buy:$258.00
Change: $4.53 (1.79%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Ex-dividend
Sell:$257.99
Buy:$258.00
Change: $4.53 (1.79%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Contact details

Address:
SUITE 800W, 2200 PENNSYLVANIA AVE. N.W.
WASHINGTON
20037-1701
United States
Telephone:
+1 (202) 8280850
Website:
https://www.danaher.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DHR
ISIN:
US2358511028
Market cap:
$183.85 billion
Shares in issue:
727.08 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Steven Rales
    Chairman of the Board
  • Rainer Blair
    President, Chief Executive Officer, Director
  • Mitchell Rales
    Co-Founder, Director
  • Matthew McGrew
    Chief Financial Officer, Executive Vice President
  • Jennifer Honeycutt
    Executive Vice President
  • Joakim Weidemanis
    Executive Vice President
  • Jose-Carlos Gutierrez-Ramos
    Senior Vice President, Chief Scientific Officer
  • Brian Ellis
    Senior Vice President, General Counsel
  • Georgeann Couchara
    Senior Vice President - Human Resources
  • William King
    Senior Vice President - Strategic Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.